Following obtaining a BA in Economics from City College of New York, Steve went into the medical device market and then the pharmaceutical market as Vice President of Sales. From this industry experience, he has built a deep appreciation of the issues that constantly face manufacturing firms. From there, he joined The Dunn Group and was Vice President for over 15 years managing business development and multiple complex competitive intelligence projects.
He consults to a wide range of large, mid-sized and small companies. Recent therapeutic categories that he has worked in include biosimilars, rheumatoid arthritis, COPD and diabetes. He focuses on competitive strategy, including sales force tactics, competitor resource allocation, and manufacturing/distribution. Steve brings invaluable knowledge on competitor tactical and regulatory issues, as well as launch strategies in multiple therapeutic markets to EMC Analytics Group.
Educated at Christ Church Oxford, England, in physics and graduating with an MA (Oxon), followed by the London School of Economics, Mike brings a combination of qualitative and quantitative real-world research skills and open-minded thinking to clients. He has worked for a number of leading strategic consulting firms including McKinsey & Co, DRI-McGraw Hill and Stanford Research Institute Consulting. Fifteen years ago he made the pharmaceutical and health care market his specialty.
For seven years, Mike guided the Healthcare Practice of the competitive intelligence firm, Fuld & Co., as Vice President and U.S. Research Director. He brings in-depth knowledge on the changing structure of the U.S. market through both federal and state legislation as well as a deep understanding of the key macro forces driving change across the healthcare market to EMC. In addition, he brings a global perspective to projects, scientific thinking, and creativity. He has extensive knowledge of therapeutic areas such as hemophilia, multiple sclerosis, pain, as well as the OTC, generics, disease management, and health insurance markets.